MIR199A2 (microRNA 199a-2) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: MIR199A2 (microRNA 199a-2) Homo sapiens
Analyze
Symbol: MIR199A2
Name: microRNA 199a-2
RGD ID: 1349796
HGNC Page HGNC:31572
Description: Enables mRNA 3'-UTR binding activity and mRNA base-pairing translational repressor activity. Involved in several processes, including negative regulation of cellular biosynthetic process; negative regulation of signal transduction; and negative regulation of transport. Acts upstream of or within negative regulation of vascular endothelial growth factor production. Located in extracellular space.
Type: ncrna (Ensembl: miRNA)
RefSeq Status: PROVISIONAL
Previously known as: MIR-199-s; mir-199a-2; MIRN199A2
RGD Orthologs
Mouse
Rat
Dog
Pig
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381172,144,535 - 172,144,644 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1172,144,535 - 172,144,644 (-)EnsemblGRCh38hg38GRCh38
GRCh371172,113,675 - 172,113,784 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361170,380,297 - 170,380,406 (-)NCBINCBI36Build 36hg18NCBI36
Celera1145,223,106 - 145,223,215 (-)NCBICelera
Cytogenetic Map1q24.3NCBI
HuRef1143,337,667 - 143,337,776 (-)NCBIHuRef
CHM1_11173,535,852 - 173,535,961 (-)NCBICHM1_1
T2T-CHM13v2.01171,501,254 - 171,501,363 (-)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
cell growth involved in cardiac muscle cell development  (ISS)
cellular response to amino acid stimulus  (ISO)
cellular response to decreased oxygen levels  (ISO)
cellular response to forskolin  (ISO)
cellular response to hypoxia  (ISO)
cellular response to inorganic substance  (ISO)
cellular response to leukemia inhibitory factor  (ISO)
cellular response to lipopolysaccharide  (ISO)
fatty acid oxidation  (ISO)
miRNA-mediated post-transcriptional gene silencing  (IDA,IEA,IMP)
negative regulation of autophagy  (ISS)
negative regulation of BMP signaling pathway  (IDA)
negative regulation of canonical Wnt signaling pathway  (IDA)
negative regulation of cardiac muscle cell apoptotic process  (ISS)
negative regulation of cardiac muscle cell proliferation  (ISS)
negative regulation of cell growth involved in cardiac muscle cell development  (ISS)
negative regulation of cell migration involved in sprouting angiogenesis  (IMP)
negative regulation of endoplasmic reticulum unfolded protein response  (IDA)
negative regulation of extrinsic apoptotic signaling pathway  (IDA)
negative regulation of fatty acid oxidation  (ISO)
negative regulation of gene expression  (IDA)
negative regulation of hepatocyte growth factor production  (IMP)
negative regulation of inflammatory response  (IMP)
negative regulation of low-density lipoprotein particle clearance  (IDA)
negative regulation of matrix metallopeptidase secretion  (IMP)
negative regulation of nitric oxide biosynthetic process  (IMP)
negative regulation of receptor internalization  (IDA)
negative regulation of SMAD protein signal transduction  (IDA)
negative regulation of transforming growth factor beta receptor signaling pathway  (IDA)
negative regulation of vascular endothelial growth factor production  (IMP)
negative regulation of vascular endothelial growth factor signaling pathway  (IMP)
ossification  (ISO)
positive regulation of angiogenesis  (IMP)
positive regulation of cardiac muscle cell proliferation  (ISS)
positive regulation of cardiac muscle hypertrophy in response to stress  (ISS)
positive regulation of cardiac muscle tissue regeneration  (ISS)
positive regulation of cell growth involved in cardiac muscle cell development  (ISS)
positive regulation of connective tissue replacement  (ISS)
positive regulation of cytosolic calcium ion concentration  (IMP)
positive regulation of endothelial cell migration  (IMP)
positive regulation of lung blood pressure  (ISS)
positive regulation of myoblast differentiation  (IMP)
positive regulation of myoblast proliferation  (IMP)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction  (ISS)
positive regulation of TOR signaling  (ISS)
re-entry into mitotic cell cycle  (ISS)
regulation of angiogenesis  (ISS)
regulation of cardiac muscle cell proliferation  (ISS)
regulation of connective tissue replacement  (ISS)
response to oxygen levels  (ISO)
sensory perception of sound  (ISO)

Cellular Component

Molecular Function

Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
References

References - curated
# Reference Title Reference Citation
1. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:12554859   PMID:12624257   PMID:15978578   PMID:16381832   PMID:17604727   PMID:18408758   PMID:20158877   PMID:20400975   PMID:21037258   PMID:21055388   PMID:21666078   PMID:22285730  
PMID:22294637   PMID:22359598   PMID:22674437   PMID:22942713   PMID:22973051   PMID:23060436   PMID:23085757   PMID:23142051   PMID:23201090   PMID:23269581   PMID:23292866   PMID:23319430  
PMID:23598416   PMID:23733518   PMID:23959088   PMID:24011070   PMID:24634990   PMID:24839982   PMID:25080937   PMID:25258381   PMID:25269744   PMID:25313882   PMID:25389292   PMID:25400809  
PMID:25444917   PMID:25448600   PMID:25588980   PMID:25706326   PMID:25839163   PMID:26065676   PMID:26160071   PMID:26163491   PMID:26251897   PMID:26307673   PMID:26346275   PMID:26399456  
PMID:26646931   PMID:26781989   PMID:26783726   PMID:26872370   PMID:26918939   PMID:26951510   PMID:26952538   PMID:27038547   PMID:27094578   PMID:27447749   PMID:27453764   PMID:27662798  
PMID:27813498   PMID:28073380   PMID:28126676   PMID:28234972   PMID:28324890   PMID:28358369   PMID:28431233   PMID:28530657   PMID:28612520   PMID:28751779   PMID:28848090   PMID:29427661  
PMID:29559347   PMID:29773428   PMID:29866054   PMID:29883549   PMID:29979193   PMID:29981373   PMID:30001527   PMID:30575906   PMID:30651148   PMID:30818424   PMID:31038761   PMID:31059001  
PMID:31081094   PMID:31140610   PMID:31255331   PMID:31386624   PMID:31451657   PMID:31539136   PMID:31608976   PMID:31809227   PMID:31841190   PMID:31957742   PMID:32063549   PMID:32111227  
PMID:32139259   PMID:32366560   PMID:32622012   PMID:32705201   PMID:33125105   PMID:33306987   PMID:33632305   PMID:33647793   PMID:33707464   PMID:33811301   PMID:34080652   PMID:34787069  
PMID:34825000   PMID:35044282   PMID:35844793   PMID:35909537   PMID:36166353   PMID:36902184   PMID:36989515   PMID:37386746   PMID:37599085   PMID:38168113  


Genomics

Comparative Map Data
MIR199A2
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381172,144,535 - 172,144,644 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1172,144,535 - 172,144,644 (-)EnsemblGRCh38hg38GRCh38
GRCh371172,113,675 - 172,113,784 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 361170,380,297 - 170,380,406 (-)NCBINCBI36Build 36hg18NCBI36
Celera1145,223,106 - 145,223,215 (-)NCBICelera
Cytogenetic Map1q24.3NCBI
HuRef1143,337,667 - 143,337,776 (-)NCBIHuRef
CHM1_11173,535,852 - 173,535,961 (-)NCBICHM1_1
T2T-CHM13v2.01171,501,254 - 171,501,363 (-)NCBIT2T-CHM13v2.0
Mir199a-2
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391162,045,383 - 162,045,492 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1162,045,383 - 162,045,492 (+)EnsemblGRCm39 Ensembl
GRCm381162,217,814 - 162,217,923 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1162,217,814 - 162,217,923 (+)EnsemblGRCm38mm10GRCm38
MGSCv371164,147,945 - 164,148,054 (+)NCBIGRCm37MGSCv37mm9NCBIm37
Celera1164,668,176 - 164,668,285 (+)NCBICelera
Cytogenetic Map1H2.1NCBI
cM Map170.06NCBI
Mir199a2
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81377,116,225 - 77,116,334 (+)NCBIGRCr8
mRatBN7.21374,582,954 - 74,583,063 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1374,582,954 - 74,583,063 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1377,152,211 - 77,152,320 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01378,459,598 - 78,459,707 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01375,719,453 - 75,719,562 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01380,125,487 - 80,125,596 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1380,125,487 - 80,125,596 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01385,019,397 - 85,019,506 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
Celera1374,334,592 - 74,334,701 (+)NCBICelera
Cytogenetic Map13q22NCBI
MIR199-2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1726,812,766 - 26,812,824 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl726,812,735 - 26,812,838 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha726,343,394 - 26,343,452 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0726,563,538 - 26,563,596 (+)NCBIROS_Cfam_1.0
UMICH_Zoey_3.1726,474,458 - 26,474,516 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0726,545,286 - 26,545,344 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0726,695,244 - 26,695,302 (+)NCBIUU_Cfam_GSD_1.0
MIR199A-1
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl9114,533,777 - 114,533,880 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.19114,533,783 - 114,533,858 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.29126,105,251 - 126,105,326 (-)NCBISscrofa10.2Sscrofa10.2susScr3


Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 1q23.1-25.1(chr1:157747246-176021247)x3 copy number gain See cases [RCV000051854] Chr1:157747246..176021247 [GRCh38]
Chr1:157717036..175990383 [GRCh37]
Chr1:155983660..174257006 [NCBI36]
Chr1:1q23.1-25.1		 pathogenic
GRCh38/hg38 1q23.3-25.2(chr1:164922655-180061589)x3 copy number gain See cases [RCV000051856] Chr1:164922655..180061589 [GRCh38]
Chr1:164891892..180030724 [GRCh37]
Chr1:163158516..178297347 [NCBI36]
Chr1:1q23.3-25.2		 pathogenic
GRCh38/hg38 1q24.3(chr1:171953097-172164645)x1 copy number loss Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053679]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053679]|See cases [RCV000053679] Chr1:171953097..172164645 [GRCh38]
Chr1:171922237..172133785 [GRCh37]
Chr1:170188860..170400408 [NCBI36]
Chr1:1q24.3		 benign
GRCh38/hg38 1q24.1-25.1(chr1:166762832-175327423)x1 copy number loss See cases [RCV000053917] Chr1:166762832..175327423 [GRCh38]
Chr1:166732069..175296559 [GRCh37]
Chr1:164998693..173563182 [NCBI36]
Chr1:1q24.1-25.1		 pathogenic
GRCh38/hg38 1q24.2-25.1(chr1:168314822-175299299)x1 copy number loss See cases [RCV000053918] Chr1:168314822..175299299 [GRCh38]
Chr1:168284060..175268435 [GRCh37]
Chr1:166550684..173535058 [NCBI36]
Chr1:1q24.2-25.1		 pathogenic
GRCh38/hg38 1q23.3-25.1(chr1:161740907-173965154)x1 copy number loss See cases [RCV000053914] Chr1:161740907..173965154 [GRCh38]
Chr1:161710697..173934292 [GRCh37]
Chr1:159977321..172200915 [NCBI36]
Chr1:1q23.3-25.1		 pathogenic
GRCh37/hg19 1q24.3(chr1:172050936-172181677) copy number loss Fetal growth restriction [RCV001797985] Chr1:172050936..172181677 [GRCh37]
Chr1:1q24.3		 likely pathogenic
GRCh38/hg38 1q24.2-25.2(chr1:169218236-178075834)x1 copy number loss See cases [RCV000137128] Chr1:169218236..178075834 [GRCh38]
Chr1:169187474..178044969 [GRCh37]
Chr1:167454098..176311592 [NCBI36]
Chr1:1q24.2-25.2		 pathogenic
GRCh38/hg38 1q24.3-31.2(chr1:170929720-191065409)x1 copy number loss See cases [RCV000142369] Chr1:170929720..191065409 [GRCh38]
Chr1:170898861..191034539 [GRCh37]
Chr1:169165485..189301162 [NCBI36]
Chr1:1q24.3-31.2		 pathogenic
GRCh38/hg38 1q23.3-25.1(chr1:163382523-175877022)x1 copy number loss See cases [RCV000143292] Chr1:163382523..175877022 [GRCh38]
Chr1:163352313..175846158 [GRCh37]
Chr1:161618937..174112781 [NCBI36]
Chr1:1q23.3-25.1		 pathogenic
GRCh38/hg38 1q24.2-31.1(chr1:170036068-187555148)x1 copy number loss See cases [RCV000143688] Chr1:170036068..187555148 [GRCh38]
Chr1:170005209..187524280 [GRCh37]
Chr1:168271833..185790903 [NCBI36]
Chr1:1q24.2-31.1		 pathogenic
GRCh38/hg38 1q21.2-25.2(chr1:149854269-180267197)x3 copy number gain See cases [RCV000143515] Chr1:149854269..180267197 [GRCh38]
Chr1:149825831..180236332 [GRCh37]
Chr1:148092455..178502955 [NCBI36]
Chr1:1q21.2-25.2		 pathogenic
GRCh37/hg19 1q23.2-25.1(chr1:160369890-175796325) copy number loss not provided [RCV000767779] Chr1:160369890..175796325 [GRCh37]
Chr1:1q23.2-25.1		 pathogenic
GRCh37/hg19 1q23.3-25.3(chr1:161676893-184071723)x1 copy number loss See cases [RCV000447098] Chr1:161676893..184071723 [GRCh37]
Chr1:1q23.3-25.3		 pathogenic
GRCh37/hg19 1q24.2-25.3(chr1:169873155-181823980)x1 copy number loss See cases [RCV000447593] Chr1:169873155..181823980 [GRCh37]
Chr1:1q24.2-25.3		 pathogenic
GRCh37/hg19 1q24.3-31.3(chr1:171990029-195086758)x1 copy number loss See cases [RCV000448686] Chr1:171990029..195086758 [GRCh37]
Chr1:1q24.3-31.3		 pathogenic
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684)x3 copy number gain See cases [RCV000510383] Chr1:849467..249224684 [GRCh37]
Chr1:1p36.33-q44		 pathogenic
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684) copy number gain See cases [RCV000510926] Chr1:849467..249224684 [GRCh37]
Chr1:1p36.33-q44		 pathogenic
GRCh37/hg19 1p36.33-q44(chr1:82154-249218992)x3 copy number gain not provided [RCV000736305] Chr1:82154..249218992 [GRCh37]
Chr1:1p36.33-q44		 pathogenic
Single allele deletion 1q24q25 microdeletion syndrome [RCV000754969] Chr1:169095250..175778910 [GRCh37]
Chr1:1q24.2-25.1		 pathogenic
GRCh38/hg38 1q24.3-31.1(chr1:171039975-186875957)x3 copy number gain See cases [RCV000134876] Chr1:171039975..186875957 [GRCh38]
Chr1:171009116..186845089 [GRCh37]
Chr1:169275740..185111712 [NCBI36]
Chr1:1q24.3-31.1		 pathogenic
GRCh37/hg19 1p36.33-q44(chr1:47851-249228449)x3 copy number gain not provided [RCV000736295] Chr1:47851..249228449 [GRCh37]
Chr1:1p36.33-q44		 pathogenic
GRCh37/hg19 1q23.2-25.2(chr1:159815642-177026983)x1 copy number loss not provided [RCV000736717] Chr1:159815642..177026983 [GRCh37]
Chr1:1q23.2-25.2		 pathogenic
GRCh37/hg19 1q24.2-25.1(chr1:167430471-174635618)x1 copy number loss not provided [RCV001005149] Chr1:167430471..174635618 [GRCh37]
Chr1:1q24.2-25.1		 pathogenic
NC_000001.10:g.(?_130980840)_(248900000_?)dup duplication Gastrointestinal stromal tumor [RCV001300221]|Parathyroid carcinoma [RCV001341077] Chr1:130980840..248900000 [GRCh37]
Chr1:1q12-44		 uncertain significance
GRCh37/hg19 1q24.2-25.3(chr1:169873155-181823980) copy number loss not specified [RCV002053713] Chr1:169873155..181823980 [GRCh37]
Chr1:1q24.2-25.3		 pathogenic
GRCh37/hg19 1q24.3-25.1(chr1:171881608-175899893) copy number loss not specified [RCV002053725] Chr1:171881608..175899893 [GRCh37]
Chr1:1q24.3-25.1		 pathogenic
GRCh37/hg19 1q24.3-31.3(chr1:171990029-195086758) copy number loss not specified [RCV002053736] Chr1:171990029..195086758 [GRCh37]
Chr1:1q24.3-31.3		 pathogenic
NC_000001.10:g.(?_171605065)_(173962123_?)dup duplication Autoimmune lymphoproliferative syndrome type 1 [RCV001939952] Chr1:171605065..173962123 [GRCh37]
Chr1:1q24.3-25.1		 uncertain significance
GRCh37/hg19 1q24.3(chr1:171649657-172399870)x1 copy number loss See cases [RCV002287554] Chr1:171649657..172399870 [GRCh37]
Chr1:1q24.3		 uncertain significance
GRCh37/hg19 1q23.3-25.1(chr1:164571371-175708060)x1 copy number loss not provided [RCV003483966] Chr1:164571371..175708060 [GRCh37]
Chr1:1q23.3-25.1		 pathogenic
GRCh37/hg19 1q24.2-31.1(chr1:167994071-187711459)x1 copy number loss not specified [RCV003987250] Chr1:167994071..187711459 [GRCh37]
Chr1:1q24.2-31.1		 pathogenic
NC_000001.10:g.(?_171605065)_(173962123_?)del deletion Autoimmune lymphoproliferative syndrome type 1 [RCV001947302]|not provided [RCV001947303] Chr1:171605065..173962123 [GRCh37]
Chr1:1q24.3-25.1		 pathogenic|uncertain significance|no classifications from unflagged records
GRCh37/hg19 1q24.2-25.3(chr1:169423492-180367623) copy number gain not provided [RCV000767621] Chr1:169423492..180367623 [GRCh37]
Chr1:1q24.2-25.3		 pathogenic

Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system visual system adipose tissue appendage entire extraembryonic component
High
Medium 2 5 2 1 13 2 7 8 8 7 56 4 4 1
Low 1667 1620 744 129 389 73 1881 967 439 108 795 905 60 1 882 1178 2
Below cutoff 258 297 258 91 44 59 581 358 397 52 133 164 32 134 365 1

Sequence


Reference Sequences
RefSeq Acc Id: ENST00000385289
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl1172,144,535 - 172,144,644 (-)Ensembl
RefSeq Acc Id: NR_029618
RefSeq Status: PROVISIONAL
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh381172,144,535 - 172,144,644 (-)NCBI
GRCh371172,113,675 - 172,113,784 (-)RGD
Celera1145,223,106 - 145,223,215 (-)RGD
HuRef1143,337,667 - 143,337,776 (-)ENTREZGENE
CHM1_11173,535,852 - 173,535,961 (-)NCBI
T2T-CHM13v2.01171,501,254 - 171,501,363 (-)NCBI
Sequence:

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:31572 AgrOrtholog
COSMIC MIR199A2 COSMIC
Ensembl Genes ENSG00000208024 Ensembl, ENTREZGENE
Ensembl Transcript ENST00000385289 ENTREZGENE
GTEx ENSG00000208024 GTEx
HGNC ID HGNC:31572 ENTREZGENE
Human Proteome Map MIR199A2 Human Proteome Map
miRBase MI0000281 ENTREZGENE
NCBI Gene 406977 ENTREZGENE
OMIM 610720 OMIM
PharmGKB PA164722570 PharmGKB
RNAcentral URS00003F2D94 RNACentral
  URS000043F622 RNACentral
  URS0000554A4F RNACentral